Study Identifies Gender Bias in HPV Vaccination
Fewer than 15% of physicians routinely recommend HPV vaccination to male patients, according to the study published in the journal Cancer Epidemiology, Biomarkers & Prevention.
Permissive guidelines, financial considerations and patient payer status may have influenced physicians’ decision-making, researchers wrote.
“HPV is responsible for almost all cases of cervical and anal cancers, as well as 64% of
In 2009, the CDC’s Advisory Committee on Immunization Practices (ACIP) issued a permissive recommendation indicating that physicians could vaccinate males aged 9 to 26 years against HPV. In 2011, the committee issued a stronger recommendation in support of routine vaccination of males ages 11 or 12 years.
Vadaparampil and colleagues conducted a mail-in survey of 746 family physicians and 473 pediatricians to examine factors associated with physician recommendations for HPV vaccination of patients ages 11 to 12 years, those aged 13 to 17 years, and those aged 18 to 26 years.
Physicians reported the frequency with which they recommended
Link to the article on Healio:
Link to the paper in Cancer Epidemiology, Biomarkers & Prevention:
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025